RadNet, Inc. (RDNT)
USD 72.41
(-5.37%)
USD 72.41
(-5.37%)
| Year | Operating Expenses | Operating Expenses Growth |
|---|---|---|
| 2023 | 268.87 Million USD | 10.8% |
| 2022 | 115.87 Million USD | 32.3% |
| 2021 | 87.58 Million USD | 44.69% |
| 2020 | 60.53 Million USD | -24.91% |
| 2019 | 80.6 Million USD | 10.57% |
| 2018 | 72.89 Million USD | 9.14% |
| 2017 | 66.79 Million USD | 0.28% |
| 2016 | 66.61 Million USD | 9.9% |
| 2015 | 60.61 Million USD | 2.28% |
| 2014 | 59.25 Million USD | 0.62% |
| 2013 | 58.89 Million USD | 1.99% |
| 2012 | 57.74 Million USD | -38.28% |
| 2011 | 93.55 Million USD | 6.32% |
| 2010 | 87.99 Million USD | 0.87% |
| 2009 | 87.23 Million USD | 2.35% |
| 2008 | 85.23 Million USD | 17.04% |
| 2007 | 72.82 Million USD | 198.53% |
| 2006 | 24.39 Million USD | 7.34% |
| 2005 | 22.72 Million USD | 4.86% |
| 2004 | 21.67 Million USD | -0.66% |
| 2003 | 21.81 Million USD | -3.0% |
| 2002 | 22.49 Million USD | 52.73% |
| 2001 | 14.72 Million USD | 29.71% |
| 2000 | 11.35 Million USD | 7.11% |
| 1999 | 10.6 Million USD | -85.93% |
| 1998 | 75.32 Million USD | 1.76% |
| 1997 | 74.02 Million USD | 26.82% |
| 1996 | 58.37 Million USD | -40.51% |
| 1995 | 98.12 Million USD | 0.0% |
| Year | Operating Expenses | Operating Expenses Growth |
|---|---|---|
| 2024 Q1 | 32.36 Million USD | -0.97% |
| 2024 Q2 | 34.47 Million USD | 6.51% |
| 2023 FY | 128.39 Million USD | 10.8% |
| 2023 Q1 | 31.31 Million USD | 2.11% |
| 2023 Q3 | 32.21 Million USD | 0.09% |
| 2023 Q4 | 32.68 Million USD | 1.48% |
| 2023 Q2 | 32.18 Million USD | 2.76% |
| 2022 Q2 | 28.86 Million USD | 6.43% |
| 2022 Q4 | 30.66 Million USD | 4.92% |
| 2022 Q3 | 29.22 Million USD | 1.27% |
| 2022 FY | 115.87 Million USD | 32.3% |
| 2022 Q1 | 27.11 Million USD | 19.98% |
| 2021 Q4 | 22.6 Million USD | -8.14% |
| 2021 Q1 | 16.4 Million USD | -26.29% |
| 2021 Q2 | 23.96 Million USD | 46.08% |
| 2021 FY | 87.58 Million USD | 44.69% |
| 2021 Q3 | 24.6 Million USD | 2.66% |
| 2020 Q4 | 22.25 Million USD | 5.86% |
| 2020 Q3 | 21.02 Million USD | 610.34% |
| 2020 Q2 | -4.12 Million USD | -118.78% |
| 2020 FY | 60.53 Million USD | -24.91% |
| 2020 Q1 | 21.93 Million USD | 7.45% |
| 2019 Q3 | 20.49 Million USD | 2.03% |
| 2019 Q2 | 20.08 Million USD | 2.36% |
| 2019 Q1 | 19.62 Million USD | 0.73% |
| 2019 FY | 80.6 Million USD | 10.57% |
| 2019 Q4 | 20.41 Million USD | -0.38% |
| 2018 Q4 | 19.47 Million USD | 11.42% |
| 2018 FY | 72.89 Million USD | 9.14% |
| 2018 Q1 | 17.85 Million USD | 8.37% |
| 2018 Q2 | 18.08 Million USD | 1.29% |
| 2018 Q3 | 17.48 Million USD | -3.35% |
| 2017 Q2 | 16.61 Million USD | -0.25% |
| 2017 Q4 | 16.47 Million USD | -3.38% |
| 2017 Q3 | 17.05 Million USD | 2.65% |
| 2017 Q1 | 16.65 Million USD | -2.43% |
| 2017 FY | 66.79 Million USD | 0.28% |
| 2016 FY | 66.61 Million USD | 9.9% |
| 2016 Q1 | 16.41 Million USD | -2.16% |
| 2016 Q2 | 15.81 Million USD | -3.66% |
| 2016 Q3 | 17.31 Million USD | 9.53% |
| 2016 Q4 | 17.06 Million USD | -1.44% |
| 2015 FY | 60.61 Million USD | 2.28% |
| 2015 Q2 | 14.94 Million USD | 4.53% |
| 2015 Q3 | 14.6 Million USD | -2.28% |
| 2015 Q4 | 16.77 Million USD | 14.89% |
| 2015 Q1 | 14.29 Million USD | 1.63% |
| 2014 Q2 | 15.19 Million USD | -2.39% |
| 2014 Q1 | 15.57 Million USD | 4.93% |
| 2014 FY | 59.25 Million USD | 0.62% |
| 2014 Q4 | 14.06 Million USD | -2.48% |
| 2014 Q3 | 14.42 Million USD | -5.11% |
| 2013 Q1 | 14.76 Million USD | 6.13% |
| 2013 FY | 58.89 Million USD | 1.99% |
| 2013 Q4 | 14.84 Million USD | 0.53% |
| 2013 Q2 | 14.52 Million USD | -1.57% |
| 2013 Q3 | 14.76 Million USD | 1.61% |
| 2012 Q4 | 13.9 Million USD | 3.52% |
| 2012 Q1 | 15.34 Million USD | -38.13% |
| 2012 Q2 | 15.05 Million USD | -1.86% |
| 2012 Q3 | 13.43 Million USD | -10.77% |
| 2012 FY | 57.74 Million USD | -38.28% |
| 2011 Q2 | 23.55 Million USD | 7.2% |
| 2011 FY | 93.55 Million USD | 6.32% |
| 2011 Q4 | 24.79 Million USD | 6.72% |
| 2011 Q3 | 23.23 Million USD | -1.36% |
| 2011 Q1 | 21.97 Million USD | 0.32% |
| 2010 FY | 87.99 Million USD | 0.87% |
| 2010 Q3 | 22.07 Million USD | -3.31% |
| 2010 Q1 | 21.08 Million USD | -3.66% |
| 2010 Q2 | 22.83 Million USD | 8.28% |
| 2010 Q4 | 21.9 Million USD | -0.79% |
| 2009 Q2 | 22.19 Million USD | 4.88% |
| 2009 FY | 87.23 Million USD | 2.35% |
| 2009 Q1 | 21.16 Million USD | -9.83% |
| 2009 Q4 | 21.88 Million USD | -1.71% |
| 2009 Q3 | 22.26 Million USD | 0.3% |
| 2008 Q2 | 21.12 Million USD | 11.4% |
| 2008 FY | 85.23 Million USD | 17.04% |
| 2008 Q3 | 21.67 Million USD | 2.59% |
| 2008 Q4 | 23.47 Million USD | 8.31% |
| 2008 Q1 | 18.96 Million USD | -2.82% |
| 2007 Q2 | 17.3 Million USD | -4.93% |
| 2007 FY | 72.82 Million USD | 198.53% |
| 2007 Q1 | 18.2 Million USD | 0.0% |
| 2007 Q3 | 17.79 Million USD | 2.83% |
| 2007 Q4 | 19.51 Million USD | 9.66% |
| 2006 FY | 24.39 Million USD | 7.34% |
| 2006 Q2 | 6.29 Million USD | 16.73% |
| 2006 Q1 | 5.39 Million USD | -0.79% |
| 2006 Q3 | 7.26 Million USD | 15.47% |
| 2005 Q2 | 5.18 Million USD | -12.38% |
| 2005 Q4 | 5.43 Million USD | -14.18% |
| 2005 Q1 | 5.92 Million USD | 13.19% |
| 2005 FY | 22.72 Million USD | 4.86% |
| 2005 Q3 | 6.33 Million USD | 22.07% |
| 2004 Q2 | 5.78 Million USD | -1.6% |
| 2004 FY | 21.67 Million USD | -0.66% |
| 2004 Q4 | 5.23 Million USD | 19.07% |
| 2004 Q1 | 5.87 Million USD | 4.48% |
| 2004 Q3 | 4.39 Million USD | -23.99% |
| 2003 Q2 | 6.37 Million USD | 88.42% |
| 2003 Q3 | 5.85 Million USD | -8.23% |
| 2003 Q4 | 5.62 Million USD | -3.93% |
| 2003 Q1 | 3.38 Million USD | -45.42% |
| 2003 FY | 21.81 Million USD | -3.0% |
| 2002 Q3 | 6.41 Million USD | 0.19% |
| 2002 Q4 | 6.2 Million USD | -3.34% |
| 2002 FY | 22.49 Million USD | 52.73% |
| 2002 Q1 | 5.13 Million USD | 13.37% |
| 2002 Q2 | 6.4 Million USD | 24.62% |
| 2001 Q2 | 3.6 Million USD | 13.97% |
| 2001 Q4 | 4.53 Million USD | -8.29% |
| 2001 Q3 | 4.94 Million USD | 37.31% |
| 2001 Q1 | 3.15 Million USD | 4.37% |
| 2001 FY | 14.72 Million USD | 29.71% |
| 2000 Q2 | 3.35 Million USD | 5.56% |
| 2000 Q1 | 3.17 Million USD | 5.95% |
| 2000 FY | 11.35 Million USD | 7.11% |
| 2000 Q4 | 3.02 Million USD | 64.44% |
| 2000 Q3 | 1.84 Million USD | -45.15% |
| 1999 Q1 | 4.6 Million USD | 48.39% |
| 1999 Q3 | 3.19 Million USD | 10.34% |
| 1999 FY | 10.6 Million USD | -85.93% |
| 1999 Q2 | 2.9 Million USD | -36.96% |
| 1999 Q4 | 3 Million USD | -6.25% |
| 1998 Q3 | 15.99 Million USD | 492.59% |
| 1998 Q2 | 2.69 Million USD | 0.0% |
| 1998 Q4 | 3.09 Million USD | -80.63% |
| 1998 FY | 75.32 Million USD | 1.76% |
| 1998 Q1 | 2.69 Million USD | 3.85% |
| 1997 Q2 | 2.79 Million USD | -0.0% |
| 1997 Q3 | 2.49 Million USD | -10.71% |
| 1997 Q4 | 2.6 Million USD | 4.0% |
| 1997 FY | 74.02 Million USD | 26.82% |
| 1997 Q1 | 2.8 Million USD | -64.56% |
| 1996 FY | 58.37 Million USD | -40.51% |
| 1996 Q3 | 3.9 Million USD | 160.0% |
| 1996 Q2 | 1.5 Million USD | -11.76% |
| 1996 Q1 | 1.69 Million USD | 0.0% |
| 1996 Q4 | 7.9 Million USD | 102.56% |
| 1995 FY | 98.12 Million USD | 0.0% |
| Name | Operating Expenses | Operating Expenses Difference |
|---|---|---|
| Bionano Genomics, Inc. | 148.99 Million USD | -80.464% |
| Prenetics Global Limited | 60.73 Million USD | -342.697% |
| Star Equity Holdings, Inc. | 16.27 Million USD | -1552.403% |
| CareDx, Inc | 277.76 Million USD | 3.2% |
| Exact Sciences Corporation | 2.06 Billion USD | 86.951% |
| Exagen Inc. | 52.29 Million USD | -414.178% |
| Inotiv, Inc. | 246.9 Million USD | -8.901% |
| Guardant Health, Inc. | 901.62 Million USD | 70.178% |
| Biodesix, Inc. | 77.41 Million USD | -247.304% |
| BioNexus Gene Lab Corp. | 3.92 Million USD | -6753.763% |
| Precipio, Inc. | 13.63 Million USD | -1871.543% |
| iSpecimen Inc. | 16.27 Million USD | -1551.868% |
| Natera, Inc. | 938.98 Million USD | 71.365% |
| Aspira Women's Health Inc. | 24.11 Million USD | -1015.033% |
| Standard BioTools Inc. | 113.48 Million USD | -136.921% |
| 23andMe Holding Co. | 420.73 Million USD | 36.093% |
| Castle Biosciences, Inc. | 242.78 Million USD | -10.749% |
| Personalis, Inc. | 128.14 Million USD | -109.826% |
| Aclaris Therapeutics, Inc. | 110.52 Million USD | -143.274% |
| Applied DNA Sciences, Inc. | 16.48 Million USD | -1530.882% |
| OpGen, Inc. | 30.65 Million USD | -777.028% |
| T2 Biosystems, Inc. | 41.49 Million USD | -547.995% |
| Myriad Genetics, Inc. | 600.1 Million USD | 55.194% |
| ICON Public Limited Company | 755.64 Million USD | 64.417% |
| NeoGenomics, Inc. | 341.25 Million USD | 21.208% |
| Star Equity Holdings, Inc. | 16.27 Million USD | -1552.403% |
| IDEXX Laboratories, Inc. | 1.09 Billion USD | 75.396% |
| MDxHealth SA | 71.25 Million USD | -277.342% |
| Psychemedics Corporation | 11.33 Million USD | -2272.322% |
| Illumina, Inc. | 3.81 Billion USD | 92.948% |
| Check-Cap Ltd. | 19.28 Million USD | -1294.094% |
| Twist Bioscience Corporation | 354.18 Million USD | 24.084% |
| DarioHealth Corp. | 62.17 Million USD | -332.469% |
| Fulgent Genetics, Inc. | 171.9 Million USD | -56.41% |
| Sera Prognostics, Inc. | 39.91 Million USD | -573.595% |
| ENDRA Life Sciences Inc. | 10.52 Million USD | -2455.705% |
| OPKO Health, Inc. | 574.68 Million USD | 53.213% |
| Medpace Holdings, Inc. | 187.68 Million USD | -43.265% |
| Neogen Corporation | 405.23 Million USD | 33.649% |
| Intelligent Bio Solutions Inc. | 11.7 Million USD | -2196.384% |
| Prenetics Global Limited | 60.73 Million USD | -342.697% |
| Mainz Biomed B.V. | 27.15 Million USD | -890.188% |
| bioAffinity Technologies, Inc. | 8.76 Million USD | -2967.699% |
| Trinity Biotech plc | 46.49 Million USD | -478.297% |
| Neuronetics, Inc. | 82.25 Million USD | -226.869% |
| Sotera Health Company | 300.46 Million USD | 10.513% |
| bioAffinity Technologies, Inc. | 8.76 Million USD | -2967.699% |